American College of Clinical Pharmacy
      Search      Cart
         

2021 Ambulatory Care Pharmacy Specialty Recertification Literature Study: Module 1A-B

Member -
Nonmember -

 


ACCP   ASHP

 

ACCP collaborates with ASHP on Ambulatory Care Pharmacy activities.

 

 

 

Target Audience

These Literature Studies are designed to help board-certified pharmacists who are seeking recertification credit hours to maintain their Board of Pharmacy Specialties (BPS).

Series Overview

The Literature Study Module provides immediate access to peer-selected, contemporary articles that are relevant to specialty practice. After learners review the content, they must successfully complete an online assessment to earn recertification credit.

Pre-Sale Date: September 22, 2021

Release date: October 20, 2021
BCACP credit expiration date: April 19, 2022
ACPE credit expiration date: October 20, 2024

Activity Overview

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 2 online home study activities. Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice.

Module 1A: Updates and Innovations in Glucose-Lowering Drugs
This module focuses on the comparative effectiveness of glucose lowering drugs in type 2 diabetes, as well as the use of SGLT2 inhibitors in non-diabetic patients.

Module 1B: Future Forward - Topics in Ambulatory Care Pharmacy
This module looks ahead to the future possibilities in ambulatory care pharmacy, including health care hotspotting, once weekly insulin, continuous glucose monitoring, flash glucose monitoring, colchicine in chronic coronary disease, and bedtime administration of antihypertensive medications.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ASHP and ACCP professional development program for BCACP recertification approved by the BPS.

Faculty
Jill Borchert, Pharm.D., BCACP, BCPS, FCCP
Professor and Vice Chair
Midwestern University Chicago College of Pharmacy
Downers Grove, Illinois
Katie Cardone, Pharm.D., BCACP, FCCP
Associate Professor
Albany College of Pharmacy and Health Sciences
Albany, New York
Diana Isaacs, Pharm.D., BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP
Endocrinology Clinical Pharmacy Specialist/Remote Monitoring Program Coordinator
Cleveland Clinic
Cleveland, Ohio
Kristin Watson, Pharm.D., BCCP
Associate Professor
University of Maryland School of Pharmacy
Baltimore, Maryland
Content Matter Experts
Genevieve M. Hale, Pharm.D., BCPS, BCCP
Assistant Professor and Vice-Chair
Nova Southeastern University College of Pharmacy
Palm Beach Gardens, Florida
Michelle L. Hilaire, Pharm.D., FCCP, BCPS, BCACP, CDE
Clinical Professor
University of Wyoming
Laramie, Wyoming
Nicholas Leon, Pharm.D., BCPS, BCACP, FCPP
Associate Professor of Pharmacy Practice
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Faculty, Content Matter Experts, Reviewers, Field Testers and Disclosures PDF

Learning Objectives

Module 1A: Updates and Innovations in Glucose-Lowering Drugs PDF

Module 1B: Future Forward - Topics in Ambulatory Care Pharmacy PDF

Continuing Pharmacy Education Credit

ACPE

The American College of Clinical Pharmacy and the American Society of Health-System Pharmacists are accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Module 1A: Updates and Innovations in Glucose-Lowering Drugs
Universal Activity Number: 0204-9999-21-977-H01-P
Contact Hours: 4.00
Activity Type: Application-Based

Module 1B: Future Forward - Topics in Ambulatory Care Pharmacy
Universal Activity Number: 0204-9999-21-978-H01-P
Contact Hours: 4.00
Activity Type: Application-Based

Methods and CE Requirements

ACPE Continuing Pharmacy Education Credit
To be eligible to earn continuing pharmacy education credit, participants must purchase the product, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by October 20, 2024. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

National Association of Boards of Pharmacy - CPE Monitor Service

Provided through the collaborative efforts of the National Association of Boards of Pharmacy (NABP), the Accreditation Council for Pharmacy Education (ACPE), and ACPE-accredited providers, the CPE Monitor Service allows you to electronically keep track of continuing pharmacy education (CPE) credits from ACPE-accredited providers. ACPE-accredited providers, like ACCP, are responsible for transmitting this information to NABP to be stored in the CPE Monitor system. Statements of credit will be available at CPE Monitor, nabp.pharmacy/cpe-monitor-service/, within 2–3 business days after completion of this activity. For more information on CPE Monitor please visit nabp.pharmacy/cpe-monitor-service/.

To transfer these credits to CPE Monitor on your behalf your NABP e-Profile ID Number and date of birth must be listed on your ACCP account. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Some international pharmacists do not use the CPE Monitor service. To verify or update this information in your ACCP account, visit Licensure/Certification. Check the box “I am an international pharmacist or I am not licensed to practice in the United States, and do not have an NABP e-Profile ID.” Be sure to save your changes at the bottom of the page.

 

BCACP Credit
Recertification Credit

 

Board certified pharmacists are eligible to receive up to 8 hours of recertification credit for completing this activity. To be eligible to earn BCACP recertification credit, participants must purchase the recertification version of this course, review all content, successfully complete, submit and pass the Web-based posttest associated with each module by April 19, 2022. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

The passing point to earn BCACP recertification credit is based on an expert analysis of the assessment items in each posttest module. Any posttest submitted before the BCACP posttest deadline that meets this passing point will earn BCACP recertification credits. These credits will be assigned as of the date of test submission. For statements of recertification credit, visit www.bpsweb.org.

All participants must have a Board of Pharmacy Specialties (BPS) board certification credential number, BPS ID Number, and a BPS expiration date on file with ACCP for reporting purposes. To verify or update this information in your ACCP account, visit Licensure/Certification. Be sure to save your changes at the bottom of the page.

Questions regarding the number of hours required for BCACP recertification should be directed to BPS at (202) 429-7591 or www.bpsweb.org.

Technical Requirements
Commercial Support

The American College of Clinical Pharmacy does not solicit or accept external commercial/financial support for its continuing pharmacy education activities. No commercial/financial support has been solicited or accepted for this activity.

 

* The credit for this product will expire on October 20, 2024.